Gastrointestinal symptoms: Some peptides, especially GLP-1 receptor agonists such as semaglutide or tirzepatide, can slow digestion, which may lead to nausea, vomiting, diarrhea, or constipation
1 Participants who were administered with the highest dose continued to lose weight throughout the study period with no evidence of a plateau
503A compounded medications are prepared by licensed state-regulated pharmacies under USP standards for individual prescriptions
The new import-level action closes the loop: rather than chase each domestic pharmacy or telehealth promoter, FDA is choking off the upstream API supply at the port
Ipamorelin, in its bid to unveil its benefits, can occasionally introduce a repertoire of side effects, including water retention, an uptick in appetite, gastrointestinal unease, the haunting presence of headaches, and the unsettling sensation of dizziness
The net result is lower blood pressure despite a harder-working heart